Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001817814 | SCV002069254 | uncertain significance | not specified | 2018-09-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001869787 | SCV002174469 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 66; Isolated neonatal sclerosing cholangitis | 2022-03-10 | criteria provided, single submitter | clinical testing | This variant, c.843_845del, results in the deletion of 1 amino acid(s) of the DCDC2 protein (p.Glu281del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs760375899, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with DCDC2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV002473303 | SCV002769923 | uncertain significance | not provided | 2024-07-10 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In-frame deletion of one amino acid in a non-repeat region |
Fulgent Genetics, |
RCV002489885 | SCV002778212 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 66; Nephronophthisis 19; Isolated neonatal sclerosing cholangitis | 2024-05-09 | criteria provided, single submitter | clinical testing |